Sialylation regulates galectin-3/ligand interplay during mammary tumour progression - a case of targeted uncloaking
Joana Oliveira(Universidade do Porto), Fátima Gärtner(Universidade do Porto), Joana Gomes(i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto), Venceslau Hespanhol(Universidade do Porto), Ana L. Santos, Emerson Soares Bernardes(Nuclear Engineering Institute), Roger Chammas(Universidade de São Paulo), Celso A. Reis(Universidade do Porto), Rita Pinto, Aki Manninen(University of Oulu), Gerard R. Rutteman(Utrecht University), Augusto-José de Matos
Cited by 28
Related Papers
Summary Report on the ISOBM TD-4 Workshop: Analysis of 56 Monoclonal Antibodies against the MUC1 Mucin
|Tumor Biology|1998|216
Toxoplasma gondii Infection Reveals a Novel Regulatory Role for Galectin-3 in the Interface of Innate and Adaptive Immunity
|American Journal Of Pathology|2006|142
Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells
|PLoS ONE|2013|124
Glycosylation of Cancer Extracellular Vesicles: Capture Strategies, Functional Roles and Potential Clinical Applications
|Cells|2021|122
MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications
|Nanomedicine Nanotechnology Biology and Medicine|2017|108